Company record · MTEX · Medicinal Chemicals & Botanical Products
Mannatech, Incorporated
Mannatech, Incorporated's chief financial officer on the record is Yasir Haider, effective June 3, 2026, per the filing record.
The record holds 1 verified CFO change for Mannatech, Incorporated from Form 8-K filings, filed June 8, 2026 and the CFO signature on its 10-K filed April 15, 2026.
The CFO seat
Computed from the records below: a move filed on or after the 10-K replaces the 10-K's signature.
| Status | Filled |
|---|---|
| Officer | Yasir Haider |
| Title as printed | Chief Financial Officer |
| Basis | Latest move: transition, 8-K filed June 8, 2026 |
Seat timeline
2Every verified record for this seat, newest first, dated as the filing states it.
2026-06-08Transition
Mannatech, Incorporated CFO transition: Yasir Haider to succeed James Clavijoeffective June 3, 2026 · 8-K filed June 8, 2026 · sec.gov, Item 5.02
2026-04-1510-K signature
Yasir Haider signed the annual report as Interim Chief Financial Officer (principal financial officer)
10-K filed April 15, 2026 · sec.gov
“/s/ Yasir Haider Yasir Haider Interim Chief Financial Officer (principal financial officer)”
Company
| Ticker | MTEX |
|---|---|
| SEC CIK | 0001056358 |
| Industry (SIC) | Medicinal Chemicals & Botanical Products (2833) |
| Roster note | The DEF 14A filed 2026-04-21 also names Yasir Haider alongside a Chief Financial Officer title. An 8-K with Item 5.02 was filed on 2026-09-01, after this 10-K; any CFO change it reports is tracked on the moves record. |
Filings on auditors and restatements
Form 8-K Item 4.01 and 4.02 filings by Mannatech, Incorporated on the disclosures record.
This record covers what the tracked filings state; it is not a complete history of the company's finance leadership. Spot an error? Send a correction.